Difference between revisions of "Team:Harvard/Team"
| Line 12: | Line 12: | ||
<br /> | <br /> | ||
| − | < | + | <div style=”line-height: 16px><font face = "open sans" size = "+3"> |
| − | Team Members </h1> | + | Team Members: </h1> |
<br/> | <br/> | ||
| Line 67: | Line 67: | ||
<br /> | <br /> | ||
| − | < | + | <div style=”line-height: 16px><font face = "open sans" size = "+3"> |
Mentor: </h1> | Mentor: </h1> | ||
Revision as of 00:44, 22 October 2019
Meet the Team!
Patrick Dickinson
Patrick Dickinson is currently a Sophomore at Harvard College studying Applied Mathematics. His hometown is Dallas, Texas and he took a gap year sailing across the Atlantic Ocean after graduating high school in 2017. The HiGEM 2019 project is his first major self-directed biological research project, though he comes to the iGEM program with some prior lab experience. Outside of SynBio, his interests include Clarinet, Piano, Sailing, and Chess.
Rahel Imru
Rahel is a junior at Harvard studying Biomedical Engineering and Global Health and Health Policy, originally from South Florida. She was brought to the iGEM team because of her interest in using synthetic biology to tackle current challenges in medicine, while assessing the ethical implications that these genetically engineered solutions come with. Outside of the lab, she enjoys volunteering in the local community through diversity initiatives and tutoring, as well as dancing.
Teagan Stedman
Teagan is a sophomore at Harvard studying Bioengineering, and is interested in using synthetic biology to treat disease, hoping to one day work on bacteria selectively colonizing tumors and delivering therapeutics. Before iGEM, he worked in the Silver Lab at Harvard Medical School on an engineered gut probiotic designed to kill foodborne pathogens, and in high school worked at UConn on rigging the motility and cell entry proteins of Listeria monocytogenes to liposomes to improve drug delivery within tumors. Outside the lab, he writes for Satire V, and loves running and comics.
Dr. Timothy Chang, PhD
Dr. Chang completed his undergraduate education in Chemical Engineering at MIT before seeking his PhD in Bioengineering at Georgia Tech. He is currently developing high throughput analysis on viral genes and their effects on intracellular signaling. In short, he is studying the viruses of today to better defend against the diseases of tomorrow.